Chen Yu-Qing, Yue Zi-Fan, Chen Sai-Nan, Tong Fei, Yang Wei-Hua, Wei Rui-Li
Department of Ophthalmology, Changzheng Hospital of Naval Medicine University, Shanghai, China.
Shenzhen Eye Hospital, Jinan University, Shenzhen, China.
Front Med (Lausanne). 2022 Sep 15;9:990538. doi: 10.3389/fmed.2022.990538. eCollection 2022.
Primary orbital lymphoma (POL) accounts for an essential part of adult orbital malignancies. Nevertheless, it remains a relatively rare lymphoid malignancy, accounting for <1% of all non-Hodgkin's lymphoma (NHL) cases. Orbital diffuse large B-cell lymphoma (DLBCL) is one of the most prevalent subtypes of POL that confers the worst outcomes. The prognostic determinants of orbital DLBCL remain unknown. Therefore, a retrospective analysis was conducted by investigating the Surveillance, Epidemiology, and End Results (SEER) database for independent predictive factors for the prognosis of orbital DLBCL.
Using the SEER program, we acquired patient data including demographics, clinical characteristics, and treatment strategies. Our cohort included cases of primary orbital DLBCL diagnosed from 2000 to 2017. We conducted Kaplan-Meier analyses to visualize the overall survival (OS) and cause-specific survival (CSS). The Cox proportional hazard regression models were applied to assess the effects of these prognostic factors on OS and CSS.
The present cohort included 332 patients with orbital DLBCL. Age was the most impacted variable by orbital DLBCL. Three independent prognostic variables of orbital DLBCL were identified on diagnosis: advanced age, no radiation treatment, and late-stage (Stage IV). Moreover, patients who underwent chemotherapy demonstrated a greater OS when compared with those who did not. In orbital DLBCL, being unmarried was also a poor prognostic factor.
The current study is the largest population-based case series of orbital DLBCL. The age at the time of diagnosis, marital status, absence of chemotherapy or radiotherapy, and tumor stage were all found to be correlated with worse prognosis.
原发性眼眶淋巴瘤(POL)是成人眼眶恶性肿瘤的重要组成部分。然而,它仍然是一种相对罕见的淋巴恶性肿瘤,占所有非霍奇金淋巴瘤(NHL)病例的不到1%。眼眶弥漫性大B细胞淋巴瘤(DLBCL)是POL最常见的亚型之一,其预后最差。眼眶DLBCL的预后决定因素尚不清楚。因此,我们通过调查监测、流行病学和最终结果(SEER)数据库,对眼眶DLBCL预后的独立预测因素进行了回顾性分析。
使用SEER计划,我们获取了包括人口统计学、临床特征和治疗策略在内的患者数据。我们的队列包括2000年至2017年诊断为原发性眼眶DLBCL的病例。我们进行了Kaplan-Meier分析,以直观显示总生存期(OS)和特定病因生存期(CSS)。应用Cox比例风险回归模型评估这些预后因素对OS和CSS的影响。
本队列包括332例眼眶DLBCL患者。年龄是受眼眶DLBCL影响最大的变量。在诊断时确定了眼眶DLBCL的三个独立预后变量:高龄、未接受放射治疗和晚期(IV期)。此外,与未接受化疗的患者相比,接受化疗的患者表现出更长的总生存期。在眼眶DLBCL中,未婚也是一个不良预后因素。
本研究是基于人群的最大眼眶DLBCL病例系列。研究发现,诊断时的年龄、婚姻状况、未进行化疗或放疗以及肿瘤分期均与较差的预后相关。